I agree that this site is using cookies. You can find further informations here.
X
van Marle Sjoerd
36  results:
Search for persons X
?
1

Pharmacokinetics, safety, and tolerability of fosmanogepix ..:

Hodges, Michael R. ; Hazel, Susan ; Kramer, William G....
Antimicrobial Agents and Chemotherapy.  68 (2024)  5 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
2

Phase 1 drug-drug interaction study to assess the effect of..:

Hodges, Michael R. ; van Marle, Sjoerd ; Kramer, William G....
Antimicrobial Agents and Chemotherapy.  , 2024
Link: https://doi.org/10.1128/..
 
?
3

Safety and Pharmacokinetics of Intravenous and Oral Fosmano..:

Hodges, Michael R. ; Ople, Eric ; Wedel, Pamela...
Antimicrobial Agents and Chemotherapy.  67 (2023)  4 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
4

Comparison of the injection‐site experience of semaglutide ..:

Snitker, Søren ; Andersen, Andreas ; Lindskov, Pernille Skøtt...
Diabetes, Obesity and Metabolism.  24 (2022)  8 - p. 1643-1646 , 2022
Link: https://doi.org/10.1111/..
 
?
5

EDP-297: a novel, highly potent, farnesoid X receptor agoni..:

Ahmad, Alaa ; Marotta, Christine ; Luo, Ed...
Journal of Hepatology.  77 (2022)  - p. S716-S717 , 2022
Link: https://doi.org/10.1016/..
 
?
6

EDP‐297: A novel, farnesoid X receptor agonist—Results of a..:

Marotta, Christine ; Ahmad, Alaa ; Luo, Ed...
Clinical and Translational Science.  16 (2022)  2 - p. 338-351 , 2022
Link: https://doi.org/10.1111/..
 
?
7

Comparison of the injection‐site experience of the starting..:

Snitker, Søren ; Andersen, Andreas ; Berg, Birgitte..
Diabetes, Obesity and Metabolism.  23 (2021)  6 - p. 1415-1419 , 2021
Link: https://doi.org/10.1111/..
 
?
8

OR23-05 Human Absorption, Metabolism, Excretion, and Absolu..:

Krasner, Alan ; van Marle, Sjoerd ; Struthers, Scott...
Journal of the Endocrine Society.  4 (2020)  Supplement_1 - p. , 2020
Link: https://doi.org/10.1210/..
 
?
9

First-in-Human Study to Assess Safety, Tolerability and Pha..:

Hodges, Michael R ; Ople, Eric ; Shaw, Karen J...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S526-S526 , 2017
Link: https://doi.org/10.1093/..
 
?
10

Safety, tolerability, pharmacokinetics and pharmacodynamics..:

Cahn, Anthony ; Hodgson, Simon ; Wilson, Robert...
BMC Pharmacology and Toxicology.  14 (2013)  1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
11

Single dose pharmacokinetics and absolute bioavailability o..:

Eltink, Charlotte ; Lee, Jennifer ; Schaddelee, Marloes...
Int. Journal of Clinical Pharmacology and Therapeutics.  50 (2012)  11 - p. 838-850 , 2012
Link: https://doi.org/10.5414/..
 
?
12

Pharmacokinetic Properties of Mirabegron, a β3-Adrenoceptor..:

Krauwinkel, Walter ; van Dijk, Jan ; Schaddelee, Marloes...
Clinical Therapeutics.  34 (2012)  10 - p. 2144-2160 , 2012
Link: https://doi.org/10.1016/..
 
?
13

Sugammadex is cleared rapidly and primarily unchanged via r..:

Peeters, Pierre ; Passier, Paul ; Smeets, Jean...
Biopharmaceutics & Drug Disposition.  32 (2011)  3 - p. 159-167 , 2011
Link: https://doi.org/10.1002/..
 
?
14

Pharmacokinetic Characterization of the Novel Pulmonary Del..:

Potocka, Elizabeth ; Cassidy, James P. ; Haworth, Pamela...
Journal of Diabetes Science and Technology.  4 (2010)  5 - p. 1164-1173 , 2010
Link: https://doi.org/10.1177/..
 
?
15

Hypertensive crisis-induced electrocardiographic changes: a..:

Farha, Khalid Abou ; van Vliet, André ; van Marle, Sjoerd..
Journal of Medical Case Reports.  3 (2009)  1 - p. 7283 , 2009
Link: https://doi.org/10.4076/..
 
1-15